Evidence-based Updates in Non-Hodgkin’s Lymphoma

Access Activity

Overview / Abstract:

Significant advances in treatment with novel agents for B-cell non-Hodgkin’s lymphoma (NHL) have improved patient outcomes and survival. However, many patients are at high-risk of relapse, meriting a precision approach to reduce the rate of recurrence and improve outcomes. The identification of molecular subtypes, the persistence of clinical challenges, and the anticipated emergence of clinical data necessitate a collaborative treatment approach to ensure individualized care for patients with diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma.

Educational Objectives - At the conclusion of this session, participants should be able to demonstrate the ability to:

- Incorporate treatment pathways and quality measures to ensure patients receive guideline-consistent care

- Evaluate the sequential and combination administration of chemotherapy and targeted agents to optimize survival in patients with lymphoma

- Discuss current recommendations for diagnostic testing for lymphoma to facilitate treatment selection

- Assess the safety and efficacy of currently approved and emerging agents for primary and subsequent management of lymphoma with attention to cost/benefit and toxicity considerations

- Evaluate resources to increase patient access and engagement

Expiration

Jan 30, 2019

Discipline(s)

Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME

Format

Webinar / Webcast / Video

Credits / Hours

AACME - 1.00 AMA PRA Category 1 Credit; ACPE - 1.00 hours (0.1 CEUs); ANCC - 1.2 contact hours; APRN - 0.5 contact hours pharmacology credit

Accreditation

Jointly provided by Potomac Center for Medical Education, Postgraduate Institute for Medicine and Rockpointe Oncology

Presenters / Authors / Faculty

Paul A. Hamlin, MD
Chief of Medical Oncology
MSKCC Basking Ridge
Associate Member Physician on the Lymphoma Service
Memorial Sloan-Kettering Cancer Center, Division of
Hematologic Oncology
Associate Professor of Medicine
Weill Medical College of Cornell University Medical College
New York, NY

Activity Specialities / Related Topics

Pharmacology, Oncology / Cancer / Radiation Therapy, Nutrition / Dietary, Hematology, Genetics

Sponsors / Supporters / Grant Providers

This activity is supported by independent educational grants from AstraZeneca, Genentech, Lilly, and Novartis Pharmaceuticals Corporation. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

Keywords / Search Terms

Rockpointe, PCME, Non-Hodgkin’s lymphoma, NHL, B-cell lymphoma, mantle cell lymphoma, follicular lymphoma, oncology, hematology, molecular subtypes, Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map